174 related articles for article (PubMed ID: 18977806)
41. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
[TBL] [Abstract][Full Text] [Related]
42. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
43. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
44. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
45. Synchronous lung tumours in a patient with metachronous colorectal carcinoma and a germline MSH2 mutation.
Canney A; Sheahan K; Keegan D; Tolan M; Hyland J; Green A
J Clin Pathol; 2009 May; 62(5):471-3. PubMed ID: 19398597
[TBL] [Abstract][Full Text] [Related]
46. Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
Shiozawa T; Konishi I
Int J Clin Oncol; 2006 Feb; 11(1):13-21. PubMed ID: 16508724
[TBL] [Abstract][Full Text] [Related]
47. Molecular characterization of endometrial cancer and therapeutic implications.
Winterhoff B; Thomaier L; Mullany S; Powell MA
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):76-83. PubMed ID: 31851045
[TBL] [Abstract][Full Text] [Related]
48. Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer.
Yen TT; Wang TL; Fader AN; Shih IM; Gaillard S
Int J Gynecol Pathol; 2020 Jan; 39(1):26-35. PubMed ID: 30741844
[TBL] [Abstract][Full Text] [Related]
49. [Genetic diagnosis of the endometrial cancer].
Kimura T; Fujita M; Kobayashi E; Ueda Y; Yoshino K; Enomoto T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():367-71. PubMed ID: 23156272
[No Abstract] [Full Text] [Related]
50. Clinical impact of molecular analysis on thyroid cancer management.
Wreesmann VB; Singh B
Surg Oncol Clin N Am; 2008 Jan; 17(1):1-35, vii. PubMed ID: 18177798
[TBL] [Abstract][Full Text] [Related]
51. Clinical actionability of molecular targets in endometrial cancer.
Urick ME; Bell DW
Nat Rev Cancer; 2019 Sep; 19(9):510-521. PubMed ID: 31388127
[TBL] [Abstract][Full Text] [Related]
52. Pathogenetic mechanisms in endometrial stromal sarcoma.
Micci F; Heim S
Cytogenet Genome Res; 2007; 118(2-4):190-5. PubMed ID: 18000370
[No Abstract] [Full Text] [Related]
53. Diagnostic analysis of two sister pairs with endometrial cancer.
Liu GB; Pang ZJ
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):239-40. PubMed ID: 15759345
[No Abstract] [Full Text] [Related]
54. Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer.
Iacobelli V; Zannoni GF; Gui B; Fagotti A; Scambia G; Fanfani F
Int J Gynecol Cancer; 2020 Jul; 30(7):1071-1076. PubMed ID: 32522776
[No Abstract] [Full Text] [Related]
55. Selected Topics in the Molecular Pathology of Endometrial Carcinoma.
Djordjevic B; Broaddus RR
Surg Pathol Clin; 2011 Mar; 4(1):131-47. PubMed ID: 26837291
[TBL] [Abstract][Full Text] [Related]
56. Survival from endometrial cancer in England and Wales up to 2001.
Kitchener HC
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S68-9. PubMed ID: 18813265
[No Abstract] [Full Text] [Related]
57. [Genetic alterations of endometrial carcinoma].
Nakao Y; Iwasaka T
Nihon Rinsho; 2012 Jun; 70 Suppl 4():303-8. PubMed ID: 23156261
[No Abstract] [Full Text] [Related]
58. Molecular basis of disease processes.
Foster CS; Gorstein F
Hum Pathol; 2001 Jun; 32(6):567-8. PubMed ID: 11431709
[No Abstract] [Full Text] [Related]
59. Molecular classification of endometrial cancer: entering an era of precision medicine.
Goulder A; Gaillard SL
J Gynecol Oncol; 2022 May; 33(3):e47. PubMed ID: 35443293
[No Abstract] [Full Text] [Related]
60. Lumping and splitting: The need for precision medicine and "personomics" in endometrial cancer.
Reyes-Baez FE; Garzon S; Mariani A
J Gynecol Oncol; 2021 Mar; 32(2):e38. PubMed ID: 33650339
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
